🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy of GSK2269557 adminis...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-03-31
Trial ID
NCT02294734
Treatments Being Tested
This study is a multi-centre, randomised, double-blind, placebo-controlled ...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-10-01
Trial ID
NCT02567708
Treatments Being Tested
GSK2269557 is a potent and highly selective inhaled Phosphoinositide 3-Kina...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-10
Trial ID
NCT02972905
Treatments Being Tested
This is a randomised, double-blind, placebo controlled, parallel group stud...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-07-31
Trial ID
NCT02130635
Treatments Being Tested
GSK2269557 is potent and highly selective inhaled phosphoinositides 3-kinas...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-01-09
Trial ID
NCT01762878
Treatments Being Tested
The purpose of this study is to evaluate specific alterations in immune cel...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-11-04
Trial ID
NCT02522299
Treatments Being Tested